Home Private Equity Private Equity Sees the Billions in Eye Care as Firms Target High-Profit...

Private Equity Sees the Billions in Eye Care as Firms Target High-Profit Procedures | News

43
0

ST. LOUIS — Christina Green hoped cataract surgery would clear up her cloudy vision, which had worsened after she took a drug to fight her breast cancer.

But the former English professor said her 2019 surgery with Ophthalmology Consultants didn’t get her to 20/20 vision or fix her astigmatism — despite a $3,000 out-of-pocket charge for the astigmatism surgical upgrade. Green, 69, said she ended up feeling more like a dollar sign to the practice than a patient.

Source link

Previous articleUS CFTC member urges ‘deep dive’ into factors behind recent commodity price swings
Next articleGovernor Newsom Announces $1.1 Billion in Small Business Support Coming to California

LEAVE A REPLY

Please enter your comment!
Please enter your name here